$\mathtt{Q^2SAR}$: overcoming classical bottlenecks in drug discovery via quantum multiple kernel learning

2026-07-13

AI Summary

Traditional QSAR models struggle to effectively capture the high-dimensional, nonlinear interactions inherent in molecular data, leading to limited predictive accuracy and increased risk of clinical failure. This work proposes a novel QSAR framework based on quantum multiple kernel learning (QMKL), which, for the first time, integrates projected quantum kernels (PQKs) with quantum support vector machines (QSVMs) to map molecular descriptors into an exponentially high-dimensional quantum Hilbert space. This approach substantially enhances the model’s capacity to represent complex nonlinear relationships. Evaluated on the DYRK1A kinase dataset, the method achieves an AUC of 0.8750, significantly outperforming classical gradient boosting models (AUC = 0.8037), thereby offering a new paradigm toward autonomous, self-optimizing drug discovery pipelines.

Abstract

Quantitative Structure-Activity Relationship ($\mathtt{QSAR}$) modeling is a foundational computational methodology in early-stage drug discovery, heavily relied upon for predicting compound toxicity, bioavailability, and therapeutic potential. However, classical methods often struggle to effectively map the highly complex, non-linear, and high-dimensional interactions inherent in molecular data, leading to reduced predictive accuracy and costly late-stage clinical failures. In this paper, we present a Quantum Multiple Kernel Learning ($\mathtt{QMKL}$) framework, dubbed Next-Gen $\mathtt{Q^2SAR}$, that leverages Quantum Support Vector Machines ($\mathtt{QSVMs}$) to overcome these classical limitations. By encoding molecular descriptors into exponentially large quantum Hilbert spaces, our approach substantially enhances the expressiveness of non-linear modeling. Benchmarking our quantum-enhanced framework on a dataset targeting the $\mathtt{DYRK1A}$ kinase (a critical target for Alzheimer's disease), the $\mathtt{QMKL}$-$\mathtt{SVM}$ achieves an impressive Area Under the Curve ($\mathtt{AUC}$) score of $0.8750$, significantly outperforming classical state-of-the-art Gradient Boosting models ($\mathtt{AUC} = 0.8037$). Furthermore, we establish a theoretical and empirical pathway toward resolving classical data bottlenecks through projected quantum kernels ($\mathtt{PQK}$) and measurement accelerators. As quantum computing architecture matures, this framework paves the way for autonomous cognitive architectures and self-improving drug discovery pipelines, promising to unlock deeper insights across vast chemical spaces and to accelerate the development of life-saving therapeutics.

Problem

• QSAR
• drug discovery
• non-linear modeling
• high-dimensional data
• predictive accuracy

Innovation

• Quantum Multiple Kernel Learning
• Quantum Support Vector Machine
• Projected Quantum Kernel
• Q²SAR
• Drug Discovery